Latest News

 Filter by Provider

Merck declines its option on Evaxion's EVX-B2 gonorrhea vaccine, leaving global rights with Evaxion and no change to its cash runway through 2027.

Impact On Carry Trade

CoreWeave is surging after joining the Energy Deptartment’s Genesis Mission to use AI to accelerate scientific breakthroughs and national security, but sustainability worries and execution risks have weighed heavily on its stock.

The U.S. Leading Economic Index fell 0.3% in September.

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

On-chain data shows Ethereum (CRYPTO: ETH) remains the blockchain with the fastest wallet growth, followed by XRP

Solana is among the biggest gainers in today's market among top-10 cryptocurrencies.

There are many streaming companies on the market, but this one gives your portfolio exposure to two of the fastest-growing assets in the world right now.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

March NY world sugar #11 (SBH26 ) today is up +0.32 (+2.21%), and March London ICE white sugar #5 (SWH26 ) is up +9.00 (+2.16%). Sugar prices are sharply higher today on short-covering as funds close out short positions ahead of the year-end Christma...

Latest financial projections suggest ByteDance will finish 2025 with net earnings close to $50 billion.

Nike "is still struggling to gain traction and continues to take longer," Needham analyst Tom Nikic wrote in a note.

Investors tend to get skittish when a company feels compelled to raise capital.

The semiconductor equipment maker has a bright future.

These could have a big effect on your retirement healthcare budget next year.

China’s Tencent Holdings has gained access to Nvidia’s Blackwell chips via a Tokyo-based cloud service provider operated, according to a report from Barron’s.

Shares of the newly listed medical equipment maker made a roaring debut on the bourses with a 41% pop.

Accenture's Q1 earnings call reveals steady increase in client demand for AI projects, but acknowledges early stages and limited scale.

FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week.

Recent trends aren't friends of this company.

Darden slipped after a slight earnings-per-share miss, even as analysts kept upbeat targets and pointed to steady demand signals.

Investors had 1.3 billion reasons to be concerned about the company's latest move.

Nike beat second-quarter estimates but its guidance missed the mark.

Sony's entertainment units agreed to buy WildBrain's stake, lifting Sony's indirect Peanuts ownership to a controlling level, pending approvals.

As the final full trading week of 2025 draws to a close, the financial markets have delivered a masterclass in volatility, pivoting from deep "AI bubble" anxieties to a late-week surge of optimism. On Friday, December 19, 2025, investors navigated a complex landscape of cooling inflation data, a landmark resolution

Stocks rallied yesterday as softer inflation data hit the tape, but Nike's latest report raises fresh questions about global demand.

The timing looks painful, but the fundamentals tell a more complicated story about why long-term investors are still paying attention.

As 2025 draws to a close, the global financial landscape is undergoing a fundamental transformation. The "Goldilocks" era of moderate growth and cooling inflation that defined much of the post-pandemic recovery has been replaced by a more aggressive regime: a high-growth, high-inflation environment that analysts are calling the "Reflation Revolution.

As the final weeks of 2025 approach, a quiet but fierce ideological war is being waged in the boardrooms of the world’s most powerful index providers. At the center of the storm is MicroStrategy (NASDAQ: MSTR), a company that has transformed from a legacy enterprise software firm into a

AnaptysBio (ANAB) has surged 227% over the past year, hitting a 5-year high. Shares have strong technical momentum and a 100% “Buy” opinion from Barchart. Analyst sentiment remains bullish, but Wall Street thinks earnings and revenue will decline nex...

Intel and TSMC are battling it out in the foundry market.

On the morning of December 19, 2025, the New York Stock Exchange was blindsided by a "mystery move" that sent shockwaves through the international tech sector. Infosys (NYSE: INFY), a bellwether for the Indian IT industry, saw its American Depositary Receipts (ADRs) skyrocket by nearly 50% within minutes of the

Vuzix expands in defense tech through extended collaboration with Collins Aerospace and RTX, progressing towards operational readiness.